September 2, 2020
The Lo Lab was awarded a supplemental R01 award from the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institute of Health (NIDDK/NIH) to study the mechanism of hyperglycemia in COVID-19 patients.
While caring for critically ill COVID-19 patients, Dr. Lo was struck by new onset diabetes and suspected that β cell failure may be the cause. Building on his lab’s research interests and expertise, he has proposed a series of experiments with specimens from COVID-19 patients to test his hypothesis and potentially provide new insight into disease mechanisms in COVID-19.